Eur Neurol. 2012;67(3):162-6. Epub 2012 Jan 20.

Natalizumab may improve cognition and mood in multiple sclerosis.

Source

Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany. christoph.lang@uk-erlangen.de

Abstract

Immunomodulating therapies may prevent relapses in multiple sclerosis and stabilize neurological status. However, little is known about the influence particularly of newer drugs on cognitive functions. We conducted an open-label prospective study to demonstrate whether natalizumab is apt to improve cognitive functions and mood in 29 patients tested psychometrically while under treatment for 6 months. We found improvements in some measures of attention, memory, mood, and well-being, but no deterioration, although patients suffered from their diseases for more than 10 years and had an EDSS score of 3.5. It is concluded that natalizumab is able to stabilize or improve cognition and mood even in longer-lasting multiple sclerosis.

PMID:: 22269396; [PubMed - in process]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Icon for S. Karger AG, Basel, Switzerland

Save items

Related citations in PubMed

Review Mitoxantrone: a review of its use in multiple sclerosis. [CNS Drugs. 2004]
Review Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ, Figgitt DP. CNS Drugs. 2004; 18(6):379-96.
The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study. [Neurol Sci. 2011]
The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study.
Mattioli F, Stampatori C, Capra R. Neurol Sci. 2011 Feb; 32(1):83-8. Epub 2010 Sep 25.
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis. [Mult Scler. 2011]
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
Phillips JT, Giovannoni G, Lublin FD, O'Connor PW, Polman CH, Willoughby E, Aschenbach W, Pace A, Hyde R, Munschauer FE. Mult Scler. 2011 Aug; 17(8):970-9. Epub 2011 Mar 18.
Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. [Clin Neurol Neurosurg. 2010]
Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis.
Velikonja O, Curić K, Ozura A, Jazbec SS. Clin Neurol Neurosurg. 2010 Sep; 112(7):597-601. Epub 2010 Apr 4.
Review Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. [Lancet Neurol. 2010]
Review Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.
Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A. Lancet Neurol. 2010 Apr; 9(4):438-46.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Natalizumab may improve cognition and mood in multiple sclerosis.
Natalizumab may improve cognition and mood in multiple sclerosis.
Eur Neurol. 2012 ;67(3):162-6. Epub 2012 Jan 20 .

PubMed
Acute management of refractory variceal bleeding in liver cirrhosis by self-expa...
Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents.
Digestion. 2012 ;85(3):185-91. Epub 2012 Jan 20 .

PubMed
Genetic instability in neural stem cells: an inconvenient truth?
Genetic instability in neural stem cells: an inconvenient truth?
J Clin Invest. 2012 Feb 1 ;122(2):484-6. doi: 10.1172/JCI62002. Epub 2012 Jan 24 .

PubMed
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk A...
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
Atherosclerosis. 2012 Mar ;221(1):169-75. Epub 2012 Jan 5 .

PubMed
Novel AGTR2 missense mutation in a Japanese boy with severe mental retardation, ...
Novel AGTR2 missense mutation in a Japanese boy with severe mental retardation, pervasive developmental disorder, and epilepsy.
Brain Dev. 2012 Jan 21. [Epub ahead of print]

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Natalizumab may improve cognition and mood in multiple sclerosis.

Source

Abstract

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information